- $2.26bn
- $1.97bn
- $1.85bn
- 86
- 55
- 76
- 85
Annual balance sheet for Innospec, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 105 | 142 | 147 | 204 | 289 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 221 | 285 | 335 | 360 | 342 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 566 | 728 | 873 | 886 | 957 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 251 | 250 | 266 | 313 | 315 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 1,397 | 1,571 | 1,604 | 1,707 | 1,735 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 252 | 337 | 406 | 372 | 371 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 453 | 539 | 566 | 560 | 524 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Other Equity | |||||
Total Equity | 944 | 1,032 | 1,038 | 1,147 | 1,211 |
Total Liabilities & Shareholders' Equity | 1,397 | 1,571 | 1,604 | 1,707 | 1,735 |
Total Common Shares Outstanding |